About Rishab Dugar

Rishab is a financial journalist and investment analyst. His investment approach is to focus on quality stocks, trading at low prices, with business models that he readily understands. Rishab majored in finance while at college and is currently a Level III candidate of the Chartered Financial Analyst (CFA) program.


Recent Articles By Rishab Dugar

: ANF |  News, Ratings, and Charts

3 Small-Cap Retailers Gaining Momentum in 2021

Small-cap retail companies have demonstrated solid business resiliency over the past year owing in part to government policies that include dovish monetary policy and wide-ranging fiscal stimuli. Despite delivering stellar returns last year, the stocks of Abercrombie & Fitch (ANF), Zumiez (ZUMZ), and Lands' End (LE) still have plenty of upside, we think, owing to an expected increase in consumer spending and adaptive business channels. Let’s take a close look at these names.
: QADA |  News, Ratings, and Charts

3 Small-Cap Growth Stocks to Buy Now

Growth stocks have led the market over the last year despite an economic slowdown. Small-cap stocks, which were more sensitive to the macroeconomic tailwinds, outperformed their large-cap peers and the broader market in general. The trend will likely continue with the stay-at-home ecosystem likely remaining unchanged. So, we think small-cap growth names QAD (QADA), A10 Networks (ATEN) and Alpha Pro Tech (APT) should be solid bets considering their impressive revenue and earnings growth potential.
: ATVI |  News, Ratings, and Charts

2 Top-Rated Video Game Stocks to Power Your Portfolio

The COVID-19-fostered remote lifestyle has bolstered the demand for virtual entertainment globally. With new strains of virus leading to the imposition of renewed lockdowns, along with a continued deepening of the remote work and play culture, we believe gaming stocks Activision Blizzard (ATVI) and Take-Two Interactive Software (TTWO) have plenty of upside.
: TAK |  News, Ratings, and Charts

2 "Strong Buy" Biotech Stocks Under $20

Most companies operating in the biotech sector have been overshadowed as investors and others have focused on companies with COVID-19 therapy drugs or vaccinations in their development pipelines or product portfolios. However, relatively low-priced companies such as Takeda Pharmaceutical (TAK) and SIGA Technologies (SIGA), with diverse product portfolios for the treatment of other critical ailments, are expected to gain traction as the COVID-19 vaccines curb the virus’ spread. Let’s look closer.
: PCRFY |  News, Ratings, and Charts

4 Top Growth Stocks Trading at a Discount

Growth stocks have delivered impressive returns on investment over the past year thanks to COVID-19-pandemic-driven trends. But we believe that as the global economy recovers from the pandemic shock, companies such as Panasonic (PCRFY), Hologic (HOLX), AGCO (AGCO), and ArcBest (ARCB) should witness further growth. Currently trading at discounts to their peers, these stocks are well-positioned to reach new highs this year.
: AMZN |  News, Ratings, and Charts

2 Buy-Rated E-Commerce Stocks to Own in 2021

The COVID-19 pandemic has precipitated a rapid adoption of online shopping. As the lines between online and offline content accessibility and customer service continue to blur, users are now turning to online channels more proactively. Hence, Amazon.com (AMZN) and eBay (EBAY) could be long-term bets given their already established infrastructure and ever-improving technology
: GNE |  News, Ratings, and Charts

3 Oil Stocks Heating up for February: Genie Energy, SilverBow Resources, and VAALCO Energy

Crude oil continues to recuperate from a wicked 2020 demand shock. The industry has responded with a successful, herculean effort to safely operate essential assets in an unprecedented and challenging period. A widespread coronavirus vaccination effort and accelerating economic activity, coupled with global supply restrictions, have renewed optimism around the industry. As a result, stocks like Genie (GNE), VAALCO (EGY) and SilverBow (SBOW) could be heating up. Curious? Let’s dig in.
: IBM |  News, Ratings, and Charts

2 Buy-Rated Value Stocks in the Technology Sector

The recent winter resurgence in coronavirus cases and the rising popularity of hybrid working ecosystems should keep the technology sector’s momentum going for the foreseeable future. With most popular tech companies currently trading at lofty valuations, relatively undervalued stocks, such as International Business Machines (IBM) and Intel (INTC), could be good bets now.
: DBX |  News, Ratings, and Charts

3 Growth Stocks Rated "Strong Buy"

While the expectation of a solid economic recovery is leading to a rotation away from growth stocks to quality undervalued stocks, it is reasonable that the continuation of some pandemic-driven trends should keep driving the performance of some growth stocks. Dropbox (DBX), RPM International (RPM) and Cirrus Logic (CRUS) boast solid growth narratives for the long-term given the ongoing digital transformation, dovish fed policy and lingering effects of coronavirus pandemic. Let’s pore over how those names are performing.
: QEP |  News, Ratings, and Charts

2 Small-Cap Oil & Gas Stocks to Add to Your Watch List

With the gradual resumption of economic activities worldwide, demand for crude oil has been recovering and is expected to return to near pre-pandemic levels in the near future. As the global economy resumes industrial production, we believe stocks like QEP Resources (QEP) and Genie Energy (GNE) should deliver decent returns.
Page generated in 1.4196 seconds.